2.4255
-0.0495
(-2.00%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-81,614.0000
-81,614.0000
-44,928.0000
-47,629.0000
-30,590.0000
Investing Cash Flow
-7,731.0000
-7,731.0000
8,868.0000
-1,793.0000
-8,557.0000
Financing Cash Flow
29,081.0000
29,081.0000
37,268.0000
25,447.0000
111,674.0000
End Cash Position
26,918.0000
26,918.0000
86,736.0000
86,553.0000
105,687.0000
Capital Expenditure
-540.0000
-540.0000
-561.0000
-534.0000
-292.0000
Issuance of Capital Stock
28,079.0000
28,079.0000
8,827.0000
25,475.0000
101,782.0000
Issuance of Debt
--
--
30,209.0000
--
9,979.0000
Repayment of Debt
-4,097.0000
-4,097.0000
-1,768.0000
-28.0000
-87.0000
Free Cash Flow
-82,154.0000
-82,154.0000
-45,489.0000
-48,163.0000
-30,882.0000
12/31/2020 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTIX Protagenic Therapeutics, Inc.
0.3690
-5.63%
EDSA Edesa Biotech, Inc.
1.9050
+0.79%
GHRS GH Research PLC
10.60
+9.39%
AKTX Akari Therapeutics, Plc
1.0900
-18.05%
PCSA Processa Pharmaceuticals, Inc.
0.6500
-0.75%
ESLA Estrella Immunopharma, Inc.
1.0500
-9.48%
FBLG FibroBiologics, Inc.
1.6100
-3.59%
IOBT IO Biotech, Inc.
0.9000
-5.26%
THAR Tharimmune, Inc.
1.9600
+0.51%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.6500
-4.62%